Recently, upon rigorous examination and assessment by the Shanghai Municipal Science and Technology Commission, Sailybio has been officially granted the Laboratory Animal Use License. The granting of the Laboratory Animal Use License constitutes a comprehensive affirmation of the Company's experimental facilities, management systems, personnel qualifications, and animal welfare safeguards. It signifies not only that the Company has obtained the statutory qualification to independently conduct animal experiments, but also demonstrates our steadfast progress along the path of research compliance and refined management. Compliance is the lifeline of the Company's development. Sailybio has consistently positioned quality and compliance at a strategic level, and has established a full-process compliance framework encompassing such key areas as laboratory animal management, biosafety, and data integrity. The acquisition of this license marks yet another significant milestone in the Company's compliance development. Going forward, we will continue to benchmark against the highest industry standards, strictly uphold the bottom line of research ethics, and advance innovation through regulation while earning trust through compliance.
